Klaria Pharma Holding AB (OSTO:KLAR) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:KLAR Klaria Pharma Holding AB OSTO:KLAR
9 GF Score
Price kr0.79
GF Value kr0.32
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Klaria Pharma Holding AB Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

OSTO:KLAR
9GF Score
Klaria Pharma Holding AB OSTO:KLAR
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Klaria Pharma Holding AB (OSTO:KLAR) Overvalued in 2026?

Based on GuruFocus' analysis, Klaria Pharma Holding AB stock appears to be overvalued. The current stock price of kr0.79 is trading 146.6% above its estimated GF Value™ of kr0.32. GuruFocus considers Klaria Pharma Holding AB to be Significantly Overvalued.

Key valuation signals for OSTO:KLAR:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: kr0.32 vs. price of kr0.79 (146.6% above fair value)
  • GF Score™: 9/100 with 6 warning signs

No single metric tells the full story. See the OSTO:KLAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Klaria Pharma Holding AB Business Description

Other Exchanges 6FN:Germany
Address Virdings Alle 2, Uppsala, CHE, 754 50
Klaria Pharma Holding AB is a Swedish pharmaceutical company that develops rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Its patented drug delivery platform consists of an alginate-based polymer film that enables the absorption of a product's active substance through the oral mucosa.
9GF Score

Get the complete analysis for OSTO:KLAR

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.79
Price
kr0.32
GF Value